Background: Prostate cancer is the most common malignancy among the male population in the United States and the 3rd most common non-skin cancer among men in Iran. Its prevalence has shown a rising trend in recent decades. The aim of this study was to report the epidemiological features of prostate cancer in patients referred for prostate biopsy in the south of Iran and to evaluate the accuracy...

Prostate cancer is the most common malignant tumor in men. The vast majority of prostate tumors are represented by prostatic adenocarcinomas (up to 95%). Sarcoma a very rare adults with formidable prognosis. Early diagnosis and radical surgery offer patients best chance cure. We report case 44-year-old patient stage VI unresectable high-grade undifferentiated sarcoma, initially presenting urina...

Background: The total serum prostate-specific antigen has been used as a screening tool to determine prostate health and is routinely done after a clinical exam which may include a digital rectal exam. The complexed prostate-specific antigen is a portion of the total prostate-specific antigen and may be a better indicator for prostate health. The purpose of this paper is to evaluate the effect ...

Prostate specific antigen (PSA) remains the most used biomarker in the management of early prostate cancer (PCa), in spite of the problems related to false positive results and overdiagnosis. New biomarkers have been proposed in recent years with the aim of increasing specificity and distinguishing aggressive from non-aggressive PCa. The emerging role of the prostate health index and the 4Kscor...

This article presents a rare case of a common disease, prostate cancer. A 57 year-old patient undergoing annual check-up for prostate cancer presents with a prostate specific antigen (PSA) level as low as 0.64 ng/ml. This patient was revealed to suffer from prostate cancer pT2c pNx pMx. This article assesses the implications of low prostate specific antigen for prostate cancer and discusses the...